Two doses of BNT162b2 (BioNTech) or Coronavac (Sinovac) vaccines are inadequate against Omicron virus variants
Researchers at the Department of Microbiology of the University of Hong Kong (HKU) have found that most individuals after given
Read moreResearchers at the Department of Microbiology of the University of Hong Kong (HKU) have found that most individuals after given
Read moreInitial findings of the phase III KEYNOTE-811 trial of pembrolizumab plus trastuzumab and chemotherapy—first presented at ASCO 2021—have led to
Read moreWASHINGTON (Reuters) – Drugmakers have targeted the U.S. market to earn outsized profits from old medicines, according to a report
Read moreA new study found that during the early months of the COVID-19 pandemic people living with HIV were less likely
Read moreA group of 16 provider and industry organizations this past week launched a campaign geared toward protecting and expanding access
Read moreEven as the U.S. closes in on a milestone of 200 million people fully vaccinated against COVID-19, cases and hospitalizations
Read moreThe Democratic Republic of Congo said Thursday that the latest Ebola outbreak was officially over, as the country marked 42
Read moreAdvances in technology and genomics have given rise to many issues, such as the extent to which genetic and lifestyle
Read more(HealthDay)—Cluster analysis applied to data from children hospitalized with acute neurologic injury supports the current paradigm that physicians use to
Read moreScientists have reported that the immune response elicited via coronavirus disease 2019 (COVID-19) vaccination or natural infection wanes off over
Read more